SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMarcus who wrote (93)3/2/1999 7:34:00 AM
From: BRAVEHEART  Read Replies (2) of 423
 
Thanks J Marcus,

Your favorite has certainly achieved the purpose of this thread. The stock has received considerable market attention since you first posted with your info. I wish I had more cash freed up to add SUNP back when you first posted. Of course I will continue to follow SUNP and may in the future consider adding it to balance a portion of my portfolio. I can only allocate a certain amt ( already a disproportionately higher percentage ) down here with the NTII's and SUNP's of the world.

PS: I have placed SCIO on my near term watch for a move to at least $13 and probably more. Especially upon approval. I would expect it to break the annual high with approval. I will look to buy between $8 and $9.5. My source has rumored that approval is near at hand. Of course this is only an anticipation. Actually I didn't expect for a longer period of FDA review. He says sooner, I say later. Keep an eye on the short position and options. They may be telling.

BEST WISHES
Jeffrey
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News